Intra-tympanic steroid injection for peripheral facial nerve palsy

Intra-tympanic steroid injection for peripheral facial nerve palsy - Intra-tympanic steroid injection for peripheral facial nerve palsy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000048662

Enrollment

Registered

2022-08-13

Start date

2016-09-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral facial palsy including Bell&#39

Interventions

Patients are injected Dexamethasone into the tympanic cavity via tympanic mambrane at least 7 times.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with peripherai facial palsy and treated with systemic steroid therapy, who have an ENoG of 10% or less after 10 days of onset Patients diagnosed with peripheral facial palsy who are at high risk of complications from steroid administration due to their general condition or comorbidities and for whom systemic administration is not possible

Exclusion criteria

Exclusion criteria: Patients with morphological abnormalities or severe infection of the external auditory canal or middle ear

Design outcomes

Primary

Measure	Time frame
Yanagihara's score, House-Brackmann grade and recovery rate 1 year after this therapy	—

Secondary

Measure	Time frame
The period taken facial nerve palsy to recover Incidence of adverse events	—

Countries

Japan

Contacts

Public ContactRie Kanai

Tazukekofukai Medical Research Institute Kitano Hospital Department of Otolaryngology, Head & Neck Surgery

riekanai.ent@gmail.com0663121221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026